Advertisement

Surgery Partners, Inc. SGRY

Set alert

Price alert · SGRY

All alert types
23.20 USD -0.01 -0.04%

As of Nov 2, 11:46 AM ET

Bid
23.19 × 1
Ask
23.20 × 2
23.18 Day range 23.23
11.41 52-week range 23.37
YTD
+50.16%
1 year
+5.79%
Open
23.21
Prev close
23.21
Mkt cap
2.99B
Vol
614.08K
Avg vol
3.37M
EPS
-0.69
P/E
0.00
Div yield
0.00%
More statistics
Low
23.18
High
23.23
Forward P/E
111.43
Beta
1.91
Short ratio
6.88
Inst. own
128.71%
Dividend
0.00
Ex-div date
Earnings
Nov 9, 2026
50-d avg
14.95
200-d avg
14.59
1y target
21.70

2Y chart

Chart tools
Interval

Events in this range
  • Aug 5, 2025Earnings: 0.17; estimate 0.16; surprise 6.25%
  • Nov 10, 2025Earnings: 0.13; estimate 0.19; surprise -31.58%
  • Mar 2, 2026Earnings: 0.12; estimate 0.31; surprise -61.29%
  • May 5, 2026Earnings: -0.03; estimate -0.15; surprise 80%
  • Aug 10, 2026Earnings: 0.1; estimate 0.05794; surprise 72.59%
  • Aug 11, 2026Rating: TD Cowen · Buy → Buy
  • Sep 14, 2026Rating: JP Morgan · Neutral → Neutral
  • Sep 18, 2026Rating: TD Cowen · Buy → Buy
  • Sep 30, 2026Rating: RBC Capital · Outperform → Outperform
  • Oct 27, 2026Downgrade: StoneX · Buy → Hold
  • Oct 28, 2026Downgrade: UBS · Buy → Neutral
Signals (110)
NameDateAgo
RSI: OverboughtOct 26, 20261 week ago
SMA: BullishOct 13, 20262 weeks ago
SMA: BullishOct 13, 20262 weeks ago
MACD: Buy SignalOct 12, 20263 weeks ago
MACD: Sell SignalOct 1, 20261 month ago
SMA: BearishSep 29, 20261 month ago
SMA: BearishSep 29, 20261 month ago
SMA: BullishSep 28, 20261 month ago
SMA: BullishSep 28, 20261 month ago
SMA: BearishSep 23, 20261 month ago
SMA: BearishSep 23, 20261 month ago
SMA: BullishSep 22, 20261 month ago
SMA: BullishSep 22, 20261 month ago
MACD: Buy SignalSep 22, 20261 month ago
MACD: Sell SignalSep 17, 20261 month ago
MACD: Buy SignalSep 1, 20262 months ago
SMA: BullishAug 12, 20262 months ago
SMA: BearishAug 11, 20262 months ago
SMA: BearishAug 11, 20262 months ago
SMA: BullishAug 7, 20262 months ago
SMA: BullishAug 7, 20262 months ago
SMA: BearishAug 6, 20262 months ago
SMA: BearishAug 5, 20262 months ago
SMA: BullishAug 3, 20263 months ago
SMA: BearishJul 31, 20263 months ago
SMA: BullishJul 28, 20263 months ago
SMA: BearishJul 27, 20263 months ago
SMA: BullishJul 24, 20263 months ago
SMA: BearishJul 22, 20263 months ago
SMA: BullishJul 15, 20263 months ago
SMA: BearishJul 14, 20263 months ago
MACD: Sell SignalJul 13, 20263 months ago
SMA: BullishJun 29, 20264 months ago
RSI: OverboughtJun 29, 20264 months ago
RSI: OverboughtJun 12, 20264 months ago
MACD: Buy SignalJun 8, 20264 months ago
SMA: BullishJun 2, 20265 months ago
SMA: BearishMay 29, 20265 months ago
SMA: BullishMay 22, 20265 months ago
SMA: BearishMay 21, 20265 months ago
MACD: Sell SignalMay 8, 20265 months ago
RSI: OverboughtApr 21, 20266 months ago
SMA: BullishApr 17, 20266 months ago
MACD: Buy SignalApr 1, 20267 months ago
RSI: OversoldMar 27, 20267 months ago
RSI: OversoldMar 20, 20267 months ago
SMA: BearishMar 3, 20268 months ago
MACD: Sell SignalMar 3, 20268 months ago
SMA: BullishFeb 20, 20268 months ago
SMA: BearishFeb 19, 20268 months ago
SMA: BullishFeb 17, 20268 months ago
MACD: Buy SignalFeb 12, 20268 months ago
RSI: OversoldFeb 5, 20269 months ago
MACD: Sell SignalJan 28, 20269 months ago
SMA: BearishJan 27, 20269 months ago
SMA: BullishJan 23, 20269 months ago
MACD: Buy SignalNov 26, 202511 months ago
RSI: OversoldNov 10, 202511 months ago
MACD: Sell SignalNov 7, 202512 months ago
SMA: BearishNov 6, 202512 months ago
SMA: BullishNov 4, 202512 months ago
SMA: BearishNov 3, 202512 months ago
SMA: BearishOct 30, 20251 year ago
SMA: BullishOct 24, 20251 year ago
SMA: BullishOct 23, 20251 year ago
MACD: Buy SignalOct 16, 20251 year ago
RSI: OversoldOct 10, 20251 year ago
MACD: Sell SignalOct 1, 20251 year ago
MACD: Buy SignalSep 29, 20251 year ago
SMA: BearishSep 8, 20251 year ago
SMA: BullishSep 5, 20251 year ago
SMA: BearishSep 4, 20251 year ago
SMA: BearishAug 26, 20251 year ago
MACD: Sell SignalAug 26, 20251 year ago
SMA: BullishAug 6, 20251 year ago
MACD: Buy SignalAug 5, 20251 year ago
MACD: Sell SignalAug 1, 20251 year ago
SMA: BearishJul 31, 20251 year ago
SMA: BullishJul 30, 20251 year ago
SMA: BearishJul 29, 20251 year ago
MACD: Buy SignalJul 29, 20251 year ago
SMA: BullishJul 28, 20251 year ago
MACD: Sell SignalJul 24, 20251 year ago
SMA: BearishJul 18, 20251 year ago
SMA: BullishJul 16, 20251 year ago
SMA: BearishJul 2, 20251 year ago
SMA: BullishJul 1, 20251 year ago
MACD: Buy SignalJun 30, 20251 year ago
SMA: BearishJun 17, 20251 year ago
RSI: OversoldJun 17, 20251 year ago
MACD: Sell SignalJun 4, 20251 year ago
MACD: Buy SignalMay 30, 20251 year ago
SMA: BullishMay 23, 20251 year ago
MACD: Sell SignalMay 23, 20251 year ago
SMA: BearishMay 21, 20251 year ago
SMA: BullishMay 12, 20251 year ago
SMA: BearishMay 8, 20251 year ago
SMA: BullishMay 2, 20251 year ago
MACD: Buy SignalApr 24, 20251 year ago
RSI: OversoldApr 21, 20251 year ago
RSI: OversoldApr 10, 20251 year ago
RSI: OversoldApr 4, 20251 year ago
MACD: Sell SignalMar 27, 20251 year ago
SMA: BearishMar 26, 20251 year ago
MACD: Buy SignalMar 21, 20251 year ago
MACD: Sell SignalFeb 20, 20251 year ago
SMA: BullishJan 28, 20251 year ago
RSI: OverboughtJan 28, 20251 year ago
RSI: OversoldDec 11, 20241 year ago
RSI: OversoldDec 5, 20241 year ago

Key statistics

Market cap
2.99B
Enterprise value
8.66B
Trailing P/E
0.00
Forward P/E
111.43
PEG ratio
0.00
Price / sales
0.89
Price / book
1.80
EPS (TTM)
-0.69
Beta
1.91
Dividend yield
0.00%
Payout ratio
0.00%
Profit margin
-2.63%
Revenue (TTM)
3.37B
Revenue growth
2.70%
Free cash flow
183.56M
Total cash
216.70M
Total debt
4.07B
Return on equity
2.32%
Shares outstanding
128.87M
Short % of float
21.69%
50-day average
14.95
200-day average
14.59

Analyst view

Consensus: buy

Buy
Price target (mean) 21.70 -6.5% downside
Target (low)
19.00
Target (mean)
21.70
Target (high)
23.50
Ratings (0m) 7 2 buy · 5 hold · 0 sell
  • Strong buy0
  • Buy2
  • Hold5
  • Sell0
  • Strong sell0

Next earnings

Nov 9, 2026

Expected Nov 9, 2026. Consensus EPS estimate 0.12467.

Earnings history

Financials — quick view

All financials
SGRY Revenue — quarterly 848.90M
2022-Q3 20222022-Q4 20222023-Q1 20232023-Q2 20232023-Q3 20232023-Q4 20232024-Q1 20242024-Q2 20242024-Q3 20242024-Q4 20242025-Q1 20252025-Q2 20252025-Q3 20252025-Q4 20252026-Q1 20262026-Q2 2026
SGRY Net income — quarterly -15.00M
2022-Q3 20222022-Q4 20222023-Q1 20232023-Q2 20232023-Q3 20232023-Q4 20232024-Q1 20242024-Q2 20242024-Q3 20242024-Q4 20242025-Q1 20252025-Q2 20252025-Q3 20252025-Q4 20252026-Q1 20262026-Q2 2026
SGRY EPS — quarterly -0.12
2022-Q3 20222022-Q4 20222023-Q1 20232023-Q2 20232023-Q3 20232023-Q4 20232024-Q1 20242024-Q2 20242024-Q3 20242024-Q4 20242025-Q1 20252025-Q2 20252025-Q3 20252025-Q4 20252026-Q1 20262026-Q2 2026

Earnings

SGRY recent earnings
Report dateQuarter endingEPS estimateEPS reportedSurpriseSurprise %
Nov 9, 2026Sep 30, 20260.1106———
Aug 10, 2026Jun 30, 20260.057940.10+0.04+72.59%
May 5, 2026Mar 31, 2026-0.15-0.03+0.12+80.00%
Mar 2, 2026Dec 31, 20250.310.12-0.19-61.29%
Nov 10, 2025Sep 30, 20250.190.13-0.06-31.58%
Aug 5, 2025Jun 30, 20250.160.17+0.01+6.25%

Upgrades / downgrades

SGRY analyst upgrades and downgrades
DateFirmActionFromTo
Oct 28, 2026UBSdownBuyNeutral
Oct 27, 2026StoneXdownBuyHold
Sep 30, 2026RBC CapitalreitOutperformOutperform
Sep 18, 2026TD CowenreitBuyBuy
Sep 14, 2026JP MorganmainNeutralNeutral
Aug 11, 2026TD CowenmainBuyBuy

About Surgery Partners, Inc.

Surgery Partners, Inc., together with its subsidiaries, owns and operates a network of surgical facilities and ancillary services in the United States. The company provides ambulatory surgery centers and surgical hospitals that offer non-emergency surgical procedures in various specialties, including orthopedics and pain management, ophthalmology, gastroenterology, and general surgery. It offers emergency departments; ancillary services such as physician practices and diagnostic testing; multi-specialty physician practices; urgent care facilities; and anesthesia services. In addition, it offers single- and multi-specialty facilities. Surgery Partners, Inc. was founded in 2004 and is headquartered in Brentwood, Tennessee.

Sector
Healthcare
Industry
Medical Care Facilities
Country
United States

News

Your note

Sign in to keep a note on SGRY — it syncs with the Stock Master app.

Insider holders

SGRY insider holders
InsiderRelationLatest transactionDateShares held
BALDOCK JENNIFER BOYDOfficerSaleMar 11, 2026326,474
BANE HARRISON ROfficerSaleSep 3, 2025117,181
BRITTENHAM MARISSAOfficerSaleMar 12, 202694,196
BURKHALTER DANIELLEOfficerSaleMar 12, 202676,864
DEVEYDT WAYNE SOfficer and DirectorStock Award(Grant)Mar 20, 2025105,203
DOHERTY DAVID T.Chief Financial OfficerSaleMar 15, 2026221,679

Institution ownership

SGRY institution ownership
Holder% heldSharesValueReported
Bain Capital Investors Llc38.15%49,946,9721.16BJun 29, 2026
Jupiter Topco LLC10.60%13,882,155322.00MJun 29, 2026
Pentwater Capital Management Lp8.88%11,630,000269.76MJun 29, 2026
UBS Group AG6.55%8,573,413198.86MJun 29, 2026
Blackrock Inc.4.77%6,241,503144.77MJun 29, 2026
King Street Capital Management, LP4.63%6,058,141140.52MJun 29, 2026

Fund ownership

SGRY fund ownership
Holder% heldSharesValueReported
JANUS INVESTMENT FUND-Janus Henderson Contrarian Fund10.13%13,258,236307.52MJun 29, 2026
VANGUARD INDEX FUNDS-Vanguard Total Stock Market Index Fund1.90%2,481,03457.55MJun 29, 2026
T. Rowe Price Small-Cap Stock Fund, Inc.1.60%2,097,59048.65MJun 29, 2026
iShares Trust-iShares Russell 2000 ETF1.58%2,063,09047.85MSep 29, 2026
VANGUARD INDEX FUNDS-Vanguard Small-Cap Index Fund1.37%1,798,43941.71MJun 29, 2026
Legg Mason Partners Investment Trust-ClearBridge Select Fund1.22%1,594,77436.99MJul 30, 2026
Advertisement